Panbela Therapeutics, Inc.: Panbela Announces Issuance of New Patent in Europe for Claims of a Novel Process for the Production of SBP-101

Monday, 14 August 2023, 14:18:00
MINNEAPOLIS, Aug. 14, 2023 (GLOBE NEWSWIRE) — Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patient…
— Finanz Nachrichten

Panbela Therapeutics Issued Patent in Europe for Claims of a Novel Process for the Production of SBP-101

Monday, 14 August 2023, 14:16:13
https://www.investing.com/news/assorted/panbela-therapeutics-issued-patent-in-europe-for-claims-of-a-novel-process-for-the-production-of-sbp101-432SI-3153569
— Investing.com

Panbela Therapeutics, Inc. (PBLA) Q2 2023 Earnings Call Transcript

Friday, 11 August 2023, 04:42:07
Panbela Therapeutics, Inc. (NASDAQ:NASDAQ:PBLA) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ETCompany ParticipantsJames Carbonara – Investor RelationsJennifer Simpson – Chief…
— Seeking Alpha

Panbela Therapeutics GAAP EPS of -$7.95 misses by $3.24

Thursday, 10 August 2023, 22:21:54
Panbela Therapeutics press release (PBLA): Q2 GAAP EPS of -$7.95 misses by $3.24.Total cash was $7.2 million as of June 30, 2023.
— Seeking Alpha

Nasdaq Moves Lower; US Crude Oil Inventories Decline Less Than Projected

Wednesday, 19 July 2023, 20:38:20
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.31% to 35,058.78 while the NASDAQ fell 0.21% to 14,323.99. The S&P 500, also rose, gaining, 0.13% to 4,560.72. Check This Out: Tesla Likely To Report Higher Q2 Earnings; Here”s A Look At Recent Price Target Changes By The Most Accurate Analysts Leading and Lagging Sectors Real estate shares climbed by 1.2% on Wednesday. In trading on Wednesday, information technology shares fell by 0.6%. Top Headline U.S. crude oil inventories declined by 0.708 million barrels in the week ended July 14, compared to market estimates of a 2.44 million-barrel draw. Equities Trading UP Harrow Health, Inc. (NASDAQ: HROW ) shares shot up 18% to $21.62 after the company acquired US & Canadian rights to certain eye disease products and announced a $60 million equity offering. Shares of Panbela Therapeutics, Inc. (NASDAQ: PBLA ) got a boost, shooting 21% to $2.5003 after the company divested certain assets in its eflornithine pediatric neuroblastoma program to US WorldMeds for $9.5 million.
— Benzinga